APO IMA 400 (Imatinib Mesylate 400 mg)
Pill with imprint APO IMA 400 is Orange, Capsule-shape and has been identified as Imatinib Mesylate 400 mg. It is supplied by Apotex Corp.
Imatinib is used in the treatment of chronic myelogenous leukemia; chronic eosinophilic leukemia; dermatofibrosarcoma protuberans; acute lymphoblastic leukemia; gastrointestinal stromal tumor and belongs to the drug class BCR-ABL tyrosine kinase inhibitors. There is positive evidence of human fetal risk during pregnancy. Imatinib 400 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for APO IMA 400
Imatinib Mesylate
- Imprint
- APO IMA 400
- Strength
- 400 mg
- Color
- Orange
- Size
- 17.00 mm
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- BCR-ABL tyrosine kinase inhibitors
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Apotex Corp.
- Inactive Ingredients
-
silicon dioxide,
crospovidone,
magnesium stearate,
hypromellose 2910 (5 mPa.s),
hydroxypropyl cellulose (type l),
ferric oxide red,
ferric oxide yellow,
polyethylene glycol 8000
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 60505-2901 | Apotex Corp. |
| 42291-0352 (Discontinued) | AvKare, Inc. |
More about imatinib
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Reviews (40)
- Drug images
- Pricing & coupons
- En español
- Drug class: BCR-ABL tyrosine kinase inhibitors
Patient resources
Other brands
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.